Related Experiment Video
Updated: May 6, 2026

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 16, 2013
Arsenic trioxide inhibits nuclear receptor function via SEK1/JNK-mediated RXRalpha phosphorylation
Koren K Mann1, Alessandra M S Padovani, Qi Guo
1Montréal Centre for Experimental Therapeutics in Cancer, Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital, McGill University, Montréal, Québec, Canada.
Abstract:
We have previously published that 2 proven treatments for acute promyelocytic leukemia, As2O3 and retinoic acid, can be antagonistic in vitro. We now report that As2O3 inhibits ligand-induced transcription of the retinoic acid receptor, as well as other nuclear receptors that heterodimerize with the retinoid X receptor alpha (RXRalpha). As2O3 did not inhibit transactivation of the estrogen receptor or the glucocorticoid receptor, which do not heterodimerize with RXRalpha. We further show that As2O3 inhibits expression of several target genes of RXRalpha partners. Phosphorylation of RXRalpha has been reported to inhibit nuclear receptor signaling, and we show by in vivo labeling and phosphoamino acid detection that As2O3 phosphorylated RXRalpha in the N-terminal ABC region exclusively on serine residues. Consistent with our previous data implying a role for JNK in As2O3-induced apoptosis, we show that pharmacologic or genetic inhibition of JNK activation decreased As2O3-induced RXRalpha phosphorylation and blocked the effects of As2O3 on RXRalpha-mediated transcription. A mutational analysis indicated that phosphorylation of a specific serine residue, S32, was primarily responsible for inhibition of RXRalpha-mediated transcription. These data may provide some insight into the rational development of chemotherapeutic combinations involving As2O3 as well as into molecular mechanisms of arsenic-induced carcinogenesis resulting from environmental exposure.
Insights
Arsenic trioxide (As2O3) inhibits retinoic acid receptor signaling in acute promyelocytic leukemia cells by phosphorylating RXRalpha. This phosphorylation, particularly at serine 32, blocks gene transcription and may inform new therapeutic strategies.
Area of Science:
- Molecular Biology
- Oncology
- Pharmacology
Background:
- Acute promyelocytic leukemia (APL) is treated with arsenic trioxide (As2O3) and retinoic acid.
- Previous studies indicated potential antagonism between As2O3 and retinoic acid in vitro.
- Nuclear receptors play critical roles in cellular signaling and gene regulation.
Purpose of the Study:
- To investigate the molecular mechanisms by which As2O3 affects nuclear receptor signaling, specifically the retinoic acid receptor (RAR).
- To determine if As2O3-induced inhibition of transcription is mediated by phosphorylation of the retinoid X receptor alpha (RXRalpha).
- To explore the role of c-Jun N-terminal kinase (JNK) in As2O3-induced effects on RXRalpha.
Main Methods:
- In vitro transcription assays to measure ligand-induced receptor activity.
- In vivo labeling and phosphoamino acid analysis to detect RXRalpha phosphorylation.
- Pharmacologic and genetic inhibition of JNK signaling pathways.
- Mutational analysis of RXRalpha to identify key phosphorylation sites.
Main Results:
- As2O3 inhibited ligand-induced transcription of RAR and other nuclear receptors that heterodimerize with RXRalpha.
- As2O3 specifically phosphorylated RXRalpha on serine residues in the N-terminal ABC region.
- Inhibition of JNK activation reduced As2O3-induced RXRalpha phosphorylation and blocked transcriptional inhibition.
- Phosphorylation of serine 32 (S32) on RXRalpha was found to be primarily responsible for the observed inhibition of transcription.
Conclusions:
- As2O3 inhibits RXRalpha-mediated transcription through direct phosphorylation of RXRalpha, particularly at S32.
- JNK signaling is involved in As2O3-induced RXRalpha phosphorylation and subsequent transcriptional inhibition.
- These findings offer insights into the development of combined chemotherapeutic regimens for APL and the molecular basis of arsenic-induced carcinogenesis.
More Related Videos
09:07Prediction and Validation of Gene Regulatory Elements Activated During Retinoic Acid Induced Embryonic Stem Cell Differentiation
Published on: June 21, 2016
09:07Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
Published on: December 19, 2018
Related Concept Videos
Co-activators and Co-repressors
Regulation of Nuclear Protein Sorting
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
MAPK Signaling Cascades
Signal Transduction: Overview
Typically, signal transduction involves three...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes: